Getting it right from the start
We know that the right development strategy for your product is critical from the very beginning to ensure an efficient pathway toward the market. Therefore, we provide a strategic partnership where we assess and understand your risks, offering planning and advice to cut time, costs, and wasted resources in product development.
In the very early days of developing a product, it can be difficult to understand what questions to ask in order to shape the product profile and develop a starting point for the development of the product. That is why we offer a free one to two-hour meeting with our Strategic Advice group which is led by our Medical Director and experienced people in Clinical Development, Medical Writing, Quality, Regulatory, Statistics, and Business Development. We offer a free consultation for new customers, the consultation is for a general Scientific advice session to chisel out initial areas to clarify, and help in formulating the questions that will help take your product further. Contact us using the form in the Strategic Group tab below to schedule your initial meeting free of charge.
From designing your Target Product Profile to submitting clinical trial applications, we offer full and flexible service solutions, and our specialist team will actively communicate with you to customize the services according to your company’s specific needs. LINK Medical services will empower your decision-making throughout the process and lay the groundwork for smooth product development.
Strategic Advice Group:
Meet the Strategic Advice team:
- Rikard Reneland, Medical Director
- Hilde Holme, Director, Regulatory Affairs
- Malin Schollin, Senior Biostatistician
- Gunnar Danielsson, Senior Regulatory Advisor
- Magnus Ringbom, Group Manager, Medical Writing
- Michael Hakenäs, Director, Business Development
“The TPP workshop gave us an excellent, clear understanding of the regulatory pathway. Having experts from different areas of the health care sector in the same room, answering all our questions, was a fantastic benefit for us”
Mohamad Takwa, CEO Thyrolytics